4D 멀레큘러 테라퓨틱스(FDMT)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $15.22 (+3.68%), 시가총액 $478.33M.
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema.
4D 멀레큘러 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
4D 멀레큘러 테라퓨틱스의 현재 주가는 $15.22 (+3.68%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
4D 멀레큘러 테라퓨틱스의 시가총액은 약 $478.33M입니다.
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic…